Squarer Ron

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -31% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Squarer Ron's trades of ADC Therapeutics SA's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
25.66
Quantity 73,326
Value US$470,001
Transaction date
Sale
Price
161.38
Quantity 20,984 +15.1%
Value US$3,227,656
Transaction date
Planned sale
Price
368.28
Quantity 74,742 +3.4%
Value US$4,581,970
Transaction date
Planned sale
Price
18.53
Quantity 113,438 -32.2%
Value US$2,101,541
Transaction date
Planned sale
Price
18.25
Quantity 100,000 -29.5%
Value US$1,825,370
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-17
PrS Proposed sale
73,326
25.66
US$470,001 		73,326 25.66 US$470,001
2024-06-18 2024-06-17
S Sale
20,984 +15.1%
161.38
US$3,227,656 		20,984 +15.1% 161.38 US$3,227,656
2019-02-08 2019-02-07
PlS Planned sale
74,742 +3.4%
368.28
US$4,581,970 		74,742 +3.4% 368.28 US$4,581,970
2019-02-01 2019-01-31
PlS Planned sale
113,438 -32.2%
18.53
US$2,101,541 		113,438 -32.2% 18.53 US$2,101,541
2019-02-01 2019-01-30
PlS Planned sale
100,000 -29.5%
18.25
US$1,825,370 		100,000 -29.5% 18.25 US$1,825,370